Join
Live feed
·
INSIDERFilingvia Quantisnow
TriSalus Life Sciences Inc. logo

Chief Financial Officer Patience David was granted 65,000 shares, increasing direct ownership by 32% to 265,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TLSI· TriSalus Life Sciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TLSI (TriSalus Life Sciences Inc.) and more on Quantisnow.